Beyond Advisers

03/26/2025

🧬 Some A.I. applications feel theoretical or far-off. This one is already changing lives.

Every Cure is using A.I. to scan 4,000+ approved drugs and match them to 18,500+ diseases - unlocking hidden treatments for patients with rare conditions who have few or no options.

Their work is saving lives now.

This story centers on Joseph Coates, who was out of options - until an A.I. model developed by Dr. David Fajgenbaum and the Every Cure team identified a life-saving drug combo hiding in plain sight.

Today, he’s in remission.

For our team at Beyond, it has been one of the greatest privileges of our work to support Every Cure - and even more meaningful to have been part of their journey since day one, when they launched on the Clinton Global Initiative stage in 2022.💡

Scientists are using machine learning to find new treatments among thousands of old medicines.

02/27/2025

DEI isn’t disappearing - it’s evolving.
As political pressure mounts and legal frameworks shift, law firms must find strategic, compliant, and values-driven ways to advance their commitments to inclusion.

In this Law360 article, Beyond Advisers CEO Scott M. Curran joins industry experts in examining how firms are reframing—not retreating—on DEI.
✅ How law firms can adapt without abandoning core commitments
✅ Why diversity remains a business and legal advantage
✅ The risks of reactive rollbacks versus strategic evolution

As Scott shares in the article, law firms are uniquely positioned to lead, ensuring their DEI efforts align with legal compliance, client needs, and competitive strategy.

Read more about the latest trends and how top firms are navigating these shifts: https://www.beyondadvisers.com/post/beyond-advisers-featured-in-law-360-article-about-challenges-faced-by-diversity-initiatives

Law firms that once led the charge on diversity initiatives now find themselves walking a tightrope, balancing their long-standing commitments to...

02/20/2025

🚨 Breakthroughs like this remind us why the work matters.
A simple, inexpensive, repurposed drug is changing lives—giving children with autism, like Mason Connor, a chance at clearer communication and cognitive growth. Leucovorin, a vitamin derivative typically used to reduce chemotherapy side effects, is proving to be a game-changer for a subset of children with autism.

This is the power of Every Cure’s mission: unlocking new treatments hiding in plain sight to save and improve lives.

We are incredibly proud to support David Fajgenbaum and Every Cure in their day-to-day work as they push the boundaries of drug discovery and turn existing medicines into new hope.

🎥 Watch this CBS News feature to see how their impact is already transforming lives.

01/14/2025

Scott shares his thoughts on the controversy surrounding HR 9495 (aka "The Nonprofit Killer Bill") - a bill designed to combat terrorism but raising concerns among nonprofits about potential misuse - with The Legal Intelligencer a publication of The American Lawyer.

Read the full article via our blog below (no paywall), where Scott unpacks the balance between national security and nonprofit integrity, highlighting fears of political overreach in an increasingly polarized environment, and explores how the nonprofit sector can remain resilient and united in the face of these challenges.

Beyond Advisers' CEO Scott M. Curran shares his thoughts on the controversy surrounding HR 9495 (aka "The Nonprofit Killer Bill") - a bill designated to combat terrorism but raising deep concerns among nonprofits about potential misuse -with The Legal Intelligencer, a publication of ALM. Read the fu...

01/12/2025

2025 isn’t wasting any time making headlines - and reminding us why doing good matters more than ever.

Global conflict. Catastrophic wildfires. Political upheaval. Firing fact-checkers....and those were just Thursday's headlines.

The latest edition of The Do (More) Good (Better) Newsletter invites you to make 2025 the year you amplify your impact - and to help us help you in that pursuit.

So:
✅ Check it out.
✅ Answer the important question it poses.
✅ Share it with others motivated to make impact in 2025.

We’re planning BIG things for 2025 and want YOU to join us.
Let’s do more good better, together!

PS. There are two ways to access the DMGB Newsletter:

1️⃣On our website via this link (sign up to get it weekly via email and see this week's online there - AND access prior editions!): https://www.beyondadvisers.com/newsletter

2️⃣ For regular LinkedIn users, on LinkedIn via the link below (Click on Einstein and subscribe to get the LinkedIn version!).

There's no wrong way to go do it and we'd love to have you join us. 2025 needs all the good YOU can do!

A new year. A fresh 12 months.

11/23/2024

Are philanthropy and nonprofits the same? Let’s explore their roles in creating impact. Plus powerful lessons from John Lewis’s Walking With The Wind.

Philanthropy, Nonprofits & the Bigger Picture 🌟 DMGB Newsletter #4

Philanthropy, Nonprofits & the Bigger Picture

11/07/2024

Beyond Advisers Weighs In: The Uncertain Path Forward for DEI in Law Firms⚖️

Scott M Curran shares his insights about what law firms should expect on ESG, DEI and wider social impact efforts if the incoming Trump administration and its supporters are empowered to continue - or enhance - their efforts.

"I'm preparing our clients for total disruption in DEI, ESG and social impact overall. We know the Trump Administration and its supporters like Project 2025 have pledged to disrupt the regulatory and enforcement environments," wrote attorney Scott Curran, CEO of social impact and legal consulting firm Beyond Advisers. "They will likely arm Stephen Miller and Ed Blum with rocket fuel for their efforts to rollback progress that's been made to level the playing field for historically marginalized communities."

Read the full article by Jon Campisi in The American Lawyer via the link below or on our blog (link in comments).

"Law firms should talk more about what they're doing," argued diversity consultant Joelle Emerson. "One of the things that makes this so controversial is that people don't know what these programs are."

10/31/2024

🌟 Introducing the Do (More) Good (Better) Newsletter 🌟

Our team at Beyond Advisers is thrilled to launch the Do (More) Good (Better) Newsletter—a must-read for those looking to make a greater impact in their work and lives. 🎉

Curated by social impact experts, this newsletter is crafted to elevate leaders in philanthropy, family offices, businesses, social enterprises, law firms, and anyone committed to positive change.

Each edition provides practical insights and inspiration, helping you make a difference in meaningful ways.

📝 What’s inside each edition?
💬 A good quote – to spark reflection
✍️ A good note – to inspire thoughtful action
🌟 A good example – highlighting real-world impact
📚 A good recommendation – book, podcast, or tool
❓ A good question – just for you! (Your answer may be featured in a future issue!)

Above all, this newsletter delivers strategies to help you do (more) good (better)—whether in your career, organization, or community.

🌍✨ Ready to take your impact further? Subscribe now and join a community committed to positive social impact.

📩 Sign up and read the first edition here:
https://www.beyondadvisers.com/newsletter

Enjoy social impact updates, insights, and tools from Beyond. Be first to receive updates, preview chapters, and free resources from the forthcoming book Do (More) Good (Better) by Scott M. Curran (Simon Acumen).

10/29/2024

Beyond Advisers’ perspective featured in Law360 article on the evolving role of law firms in ESG and social impact 🌍⚖️

Here are three key takeaways from Scott M. Curran's contributions to the article:

1️⃣ Deeply Committed Law Firms Persist: Those with a longstanding culture and commitment to social impact work continue to thrive and adapt, having integrated these values long before DEI became a mainstream priority and without regard to what happens to the acronym's use.

2️⃣ Evolving Communication: Many firms have adjusted their approaches and communication around social impact, reflecting both timeless values and contemporary needs. 🔄📢

3️⃣ Susceptibility to Trends: Firms with less deeply ingrained commitments may be more susceptible to changing headlines and external pressures but should continue their efforts and seek assistance from the models others have pioneered. 📰

This is a crucial topic for the legal profession, and we’re grateful to Aebra Coe and for highlighting these issues and insights.

We’re also honored to be included alongside leaders in the law firm Impact and ESG space like Pamela Cone, ISSP-SA, and Shauna C. Bryce, JD! 🌟

Law 360: "Law Firms Diverge As Anti-ESG Pushback Continues."

10/10/2024

Congratulations to Every Cure on this incredible award from TED's The Audacious Project!
We are BEYOND excited to see all the incredible life saving work that results from this transformative grant!

02/29/2024

This $48.3M funding is an extraordinary milestone for Every Cure, and a MAJOR moment for the future of medicine, science, technology, and saving the lives of 1 in 10 people each of us know and love.

This landmark funding from Advanced Research Projects Agency for Health (ARPA-H) announced yesterday at The White House will help Every Cure and its partners identify the true potential of every single one of the 3,000 FDA-approved medicines to treat every human disease possible.

And this is just the beginning of the next phase of Every Cure's extraordinary growth. Our team is Beyond proud to work with David Fajgenbaum, Tracey Sikora, Grant W Mitchell, MD, MBA and the rest of the Every Cure team and to see their mission to save every life possible.

THIS is ! Congratulations to Every Cure!

ARPA-H contract will supercharge Every Cure’s work to identify existing medicines that can be repurposed to treat currently untreated diseases.